Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
SLIViT: a general AI framework for accurate clinical-feature diagnosis from limited 3D medical-imaging data
Author Affiliations & Notes
  • Oren Avram
    Computational Medicine, University of California Los Angeles, Los Angeles, California, United States
    Computer Science, University of California Los Angeles, Los Angeles, California, United States
  • Berkin Durmus
    Computational Medicine, University of California Los Angeles, Los Angeles, California, United States
    Computer Science, University of California Los Angeles, Los Angeles, California, United States
  • Nadav Rakocz
    Computer Science, University of California Los Angeles, Los Angeles, California, United States
  • Giulia Corradetti
    Doheny Eye Institute, Los Angeles, California, United States
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
  • Ilan Gronau
    Reichman University Efi Arazi School of Computer Science, Herzeliya, Israel
  • Sriram Sankararaman
    Computational Medicine, University of California Los Angeles, Los Angeles, California, United States
    Computer Science, University of California Los Angeles, Los Angeles, California, United States
  • Jeffrey N. Chiang
    Computational Medicine, University of California Los Angeles, Los Angeles, California, United States
  • SriniVas R Sadda
    Doheny Eye Institute, Los Angeles, California, United States
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
  • Eran Halperin
    Computational Medicine, University of California Los Angeles, Los Angeles, California, United States
    Computer Science, University of California Los Angeles, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Oren Avram None; Berkin Durmus None; Nadav Rakocz None; Giulia Corradetti None; Ilan Gronau None; Sriram Sankararaman None; Jeffrey Chiang None; SriniVas Sadda 4DMT, Abbvie, Alexion, Allergan Inc., Alnylam Pharmaceuticals, Amgen Inc., Apellis Pharmaceuticals, Inc., Astellas, Bayer Healthcare Pharmaceuticals, Biogen MA Inc., Boehringer Ingelheim, Carl Zeiss Meditec, Catalyst Pharmaceuticals Inc., Centervue Inc., GENENTECH, Gyroscope Therapeutics, Heidelberg Engineering, Hoffman La Roche, Ltd., Iveric Bio, Janssen Pharmaceuticals Inc., Nanoscope, Notal Vision Inc., Novartis Pharma AG, Optos Inc., Oxurion/Thrombogenics, Oyster Point Pharma, Regeneron Pharmaceuticals Inc., Samsung Bioepis, Topcon Medical Systems Inc., Code C (Consultant/Contractor), Carl Zeiss Meditec, Heidelberg Engineering, Optos Inc., Nidek, Topcon, Centervue, Code F (Financial Support), Carl Zeiss Meditec, Heidelberg Engineering, Nidek Incorporated, Novartis Pharma AG, Topcon Medical Systems Inc., Code R (Recipient); Eran Halperin Optum, Code E (Employment)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1614. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Oren Avram, Berkin Durmus, Nadav Rakocz, Giulia Corradetti, Ilan Gronau, Sriram Sankararaman, Jeffrey N. Chiang, SriniVas R Sadda, Eran Halperin; SLIViT: a general AI framework for accurate clinical-feature diagnosis from limited 3D medical-imaging data. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1614.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Medical imaging analysis is a critical component of clinical care. For instance, analyzing optical coherence tomography (OCT) images allows ophthalmologists to diagnose and follow up on ocular diseases, such as age-related macular degeneration (AMD), and tailor appropriate and personalized interventions to delay the progression of retinal atrophy and irreversible vision loss. AI models could potentially automate these analyses and improve healthcare by reducing costs and treatment burden. However, procuring thousands of annotated medical-imaging samples, specifically volumetric modalities (e.g., 3D OCT), to train standard AI models is cost- and expert-time-prohibitive, impeding their full optimization.

Methods : We developed the SLice Integration by Vision Transformer (SLIViT), a uniform 3D-based AI framework that leverages an exclusive combination of deep-learning modules and prior 'knowledge’ obtained from 2D OCT scans. This unique combination enables it to overcome the annotation bottleneck and excel in various 3D-OCT-related learning tasks. Interestingly, SLIViT’s prior 'retinal knowledge’ can be translated to other 3D-medical-imaging modalities, such as echocardiogram videos and 3D magnetic resonance imaging (MRI) scans.

Results : We compared the performance of SLIViT in four binary-classification tasks of AMD biomarkers, including large drusen volume, intraretinal hyperreflective foci, subretinal drusen deposits, and hyporeflective drusen cores, using less than 700 annotated training samples. We also compared its performance in regression tasks of cardiac function diagnosis in echocardiogram videos and severity assessment of a hepatic-disease from 3D MRI scans. SLIViT consistently and significantly outperformed domain-specific state-of-the-art AI models, typically improving the performance score (AUC or R2) by 0.1-0.4 (p-value<0.001). SLIViT’s accuracy on the binary-classification tasks was also compared to retina specialists’ assessment and found to be on par, 5,000x faster.

Conclusions : SLIViT is adept at 3D-medical-imaging learning tasks, in which the number of annotated training samples is typically very limited. It significantly transcends strong AI models while achieving on-par performance to clinical specialists’ manual annotation. Thus it can be used to save resources, reduce the burden on clinicians, expedite ongoing research, and consequently, improve patient healthcare.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×